Prosecution Insights
Last updated: October 02, 2026
Application No. 17/925,456

ENDOSCOPE

Non-Final OA §103
Filed
Nov 15, 2022
Priority
Sep 29, 2020 — JP 2020-163438 +1 more
Examiner
WU, PAMELA F
Art Unit
3795
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Hoya Corporation
OA Round
3 (Non-Final)
57%
Grant Probability
Moderate
3-4
OA Rounds
0m
Est. Remaining
80%
With Interview

Examiner Intelligence

Grants 57% of resolved cases
57%
Career Allowance Rate
165 granted / 288 resolved
-12.7% vs TC avg
Strong +22% interview lift
Without
With
+22.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
35 currently pending
Career history
342
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
42.1%
+2.1% vs TC avg
§102
17.8%
-22.2% vs TC avg
§112
30.8%
-9.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 288 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Status of Claims Claims 1-3 and 8-9 are pending, claims 4-7 have been cancelled, and claims 1-3 and 8-9 are currently under consideration for patentability under 37 CFR 1.104. Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 04/20/2026 has been entered. Response to Arguments Applicant’s arguments with respect to claim(s) 1-3 and 8-9 have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 1-3 and 8-9 are rejected under 35 U.S.C. 103 as being unpatentable over Maahs (US 2013/0041214), in view of Sahney (US 2015/0374221) and Larkin (US 2008/0071290). Regarding claim 1, Maahs discloses an endoscope including an insertion portion (360, figures 38a and 45a) having a round tubular shape to be inserted into a body lumen (see figure 45a; for a body lumen…[0004]), the endoscope comprising: a treatment tool passage (instrument lumens 366, figures 38a and 45a) having one end opened on a distal tip surface of the insertion portion (see figure 38a), penetrating the insertion portion in an axial length direction (see figure 38a), and allowing a treatment tool to pass through (various instruments passed through…lumens 366 [0149]); and a fluid passage (working lumen…injection of fluids [0003]); the fluid passage penetrating the insertion portion in the axial length direction (see figure 38a). Maahs is silent regarding the fluid passage having an outlet opened on the distal tip surface of the insertion portion and an inlet on a proximal end of the fluid passage for receiving a fluid, the fluid passage allowing a perfusing of the fluid that is supplied from the inlet to the outlet to flow out of the distal tip surface of the insertion portion through the insertion portion in the axial length direction, wherein the treatment tool passage and the fluid passage partially overlap in a cross- sectional view that is perpendicular to the axial length direction, and wherein the treatment tool passage and the fluid passage each have a substantially circular shape in the cross-sectional view, such that the treatment tool passage and the fluid passage are closed to an outer surface of the endoscope along the axial length direction. Sahney teaches a system (100, figure 1) with an operative member (120, figure 2a). The operative member receives internally a surgical tool (122, figure 2a). Inflow of liquid can be through the operative member (see 107, figure 2a) to distend and irrigate an organ of a patient ([0025]). Larkin teaches a guide tube (2002, figure 20a) with channels ([0237]). One channel accommodates an endoluminal imaging system (2004, figure 20a) and another channel (2006, figure 20a) is an optical auxiliary channel that may be used for irrigation, suction, small instruments, etc. ([0238]). The third channel (2008, figure 20a) is shaped to accommodate two surgical instruments ([0239]). One of the channels (2004, figure 20a) has a circular bore (2004a, figure 20a) to accommodate the imaging system’s body and slots (2004b, figure 20a) on either side of the circular bore to allow the image capture element pass ([0237]). The circular bore (2004a, figure 20a) has a slightly larger diameter than the slots (2004b, figure 20a), which allows the imaging system to be held in place within the channel ([0237]). The channel may have various cross-sectional shapes ([0237]), like a rounded rectangle or circular ([0241]). It would have been obvious to one of ordinary skill in the art before the time of filing to modify the endoscope of Maahs to have the treatment tool passage and fluid passage connected (see 107 and 120, figure 2a; Sahney) as taught by Sahney. Doing so would distend and irrigate an organ of a patient ([0025]; Sahney). Additionally, it would have been obvious to modify the treatment tool passage and fluid passage to have a circular bore (2004a, figure 20a) and slots (2004b, figure 20a) respectively as taught by Larkin. Doing so would provide a shape that can hold an instrument in place within the channel ([0237]). The modified endoscope would have the fluid passage having an outlet opened on the distal tip surface of the insertion portion and an inlet on a proximal end of the fluid passage for receiving a fluid (inflow of a liquid [0025]; see 107, figure 2a of Sahney), the fluid passage allowing a perfusing of the fluid that is supplied from the inlet to the outlet to flow out of the distal tip surface of the insertion portion through the insertion portion in the axial length direction (see 107, figure 2a; Sahney), wherein the treatment tool passage and the fluid passage partially overlap in a cross- sectional view that is perpendicular to the axial length direction (best seen with 520 in lumen 364, figure 45a of Maahs | see 107 and 120, figure 2a of Sahney | the modified endoscope would have the fluid passage be in the space of the lumen surrounding the treatment tool passage; i.e., suction occurs in the space around 520, figure 45a of Maahs), and wherein the treatment tool passage and the fluid passage each have a substantially circular shape in the cross-sectional view (cross-sectional shapes…road, oval…[0237]; Larkin), such that the treatment tool passage and the fluid passage are closed to an outer surface of the endoscope along the axial length direction (see location of instrument lumens 366, figures 38a and 45a of Maahs). Regarding claim 2, Larkin further teaches the treatment tool passage is larger in diameter than the fluid passage (see diameter of 2004a vs 2004b, figure 20a; Larkin | circular bore 2004a has a slightly larger diameter than slots 2004b [0237]). Regarding claim 3, Maahs and Larkin further disclose a distance from an axial center of the insertion portion to the fluid passage is equal to or longer than a distance from the axial center of the insertion portion to the treatment tool passage (best seen with 520 in 364, figure 45a; Maahs | see 2004a vs. 2004b, figure 20a of Larkin). Regarding claim 8, Maahs and Larkin further disclose the fluid passage includes two fluid passages that are formed to face each other in a radial direction of the treatment tool passage (see the two spaces on either side of 520 in 364, figure 45a of Maahs | see 2004b with 2004a in between, figure 20a of Larkin). Regarding claim 9, Maahs and Sahney and Larkin further disclose the treatment tool passage and the two fluid passages are integrated to form a single hole that includes two major arc-shaped parts (see outer perimeter of 2004b, figure 20a; Larkin) relating to the two fluid passages (see 107 around 120, figure 2a; Sahney) and two minor arc- shaped parts (see outer perimeter of 2004a, figure 20a) relating to the treatment tool passage (best seen with 520 in lumen 364, figure 45a of Maahs | see tool 122 in 120, figure 2a; Sahney). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to PAMELA F WU whose telephone number is (571)272-9851. The examiner can normally be reached M-F: 8-4 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Michael Carey can be reached at 571-270-7235. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. PAMELA F. WU Examiner Art Unit 3795 September 5, 2026 /RYAN N HENDERSON/Primary Examiner, Art Unit 3795
Read full office action

Prosecution Timeline

Show 4 earlier events
Jul 31, 2025
Examiner Interview Summary
Aug 28, 2025
Response Filed
Dec 29, 2025
Final Rejection mailed — §103
Mar 16, 2026
Response after Non-Final Action
Apr 20, 2026
Request for Continued Examination
Apr 22, 2026
Response after Non-Final Action
Sep 14, 2026
Non-Final Rejection mailed — §103
Oct 01, 2026
Interview Requested

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12714288
ENDOSCOPE SYSTEM AND OPERATION METHOD FOR ENDOSCOPE SYSTEM
3y 0m to grant Granted Aug 25, 2026
Patent 12714289
MEDICAL IMAGING SYSTEM WITH CUSTOMIZABLE PROGRAMMABLE COMMANDS
2y 3m to grant Granted Aug 25, 2026
Patent 12708461
SYSTEMS AND METHODS FOR ROBOTIC BRONCHOSCOPY
4y 2m to grant Granted Aug 18, 2026
Patent 12708255
SYSTEMS AND METHODS FOR MODULAR ENDOSCOPE
4y 2m to grant Granted Aug 18, 2026
Patent 12708478
SYSTEMS AND METHODS FOR MEDICAL IMAGING
2y 10m to grant Granted Aug 18, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
57%
Grant Probability
80%
With Interview (+22.2%)
3y 4m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 288 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month